- Home
- TYRA vs TREE Comparison
TYRA vs TREE Comparison
Compare TYRA & TREE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TYRA
- TREE
- Stock Information
- Founded
- TYRA 2018
- TREE 1996
- Country
- TYRA United States
- TREE United States
- Employees
- TYRA 38
- TREE N/A
- Industry
- TYRA Biotechnology: Pharmaceutical Preparations
- TREE Finance: Consumer Services
- Sector
- TYRA Health Care
- TREE Finance
- Exchange
- TYRA Nasdaq
- TREE Nasdaq
- Market Cap
- TYRA 666.4M
- TREE 627.6M
- IPO Year
- TYRA 2021
- TREE N/A
- Fundamental
- Price
- TYRA $13.17
- TREE $41.27
- Analyst Decision
- TYRA Strong Buy
- TREE Buy
- Analyst Count
- TYRA 6
- TREE 8
- Target Price
- TYRA $30.50
- TREE $64.00
- AVG Volume (30 Days)
- TYRA 247.2K
- TREE 192.8K
- Earning Date
- TYRA 03-18-2025
- TREE 03-05-2025
- Dividend Yield
- TYRA N/A
- TREE N/A
- EPS Growth
- TYRA N/A
- TREE N/A
- EPS
- TYRA N/A
- TREE N/A
- Revenue
- TYRA N/A
- TREE $773,050,000.00
- Revenue This Year
- TYRA N/A
- TREE $32.81
- Revenue Next Year
- TYRA N/A
- TREE $15.99
- P/E Ratio
- TYRA N/A
- TREE N/A
- Revenue Growth
- TYRA N/A
- TREE 4.44
- 52 Week Low
- TYRA $11.89
- TREE $28.50
- 52 Week High
- TYRA $29.60
- TREE $62.49
- Technical
- Relative Strength Index (RSI)
- TYRA 43.64
- TREE 41.57
- Support Level
- TYRA $12.27
- TREE $44.00
- Resistance Level
- TYRA $13.79
- TREE $47.79
- Average True Range (ATR)
- TYRA 0.71
- TREE 1.70
- MACD
- TYRA 0.03
- TREE -0.51
- Stochastic Oscillator
- TYRA 51.09
- TREE 2.10
About TYRA Tyra Biosciences Inc.
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology The Company's in-house precision medicine platform, SNÅP, enables rapid and precise drug design through iterative molecular SNAPshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. Its lead product candidate is TYRA 300, an FGFR3 selective inhibitor with an initial focus on patients with metastatic urothelial carcinoma of the bladder and urinary tract (mUC).
About TREE LendingTree Inc.
LendingTree Inc is a United States-based company that is principally engaged in operating an online loan marketplace. The company provides online tools and resources that can help consumers find loans or other credit-based offerings They need, including mortgage loans, reverse mortgage, home equity, personal loans, auto loans, credit cards, student loans, small business loans, and other related offerings. The company offers consumers direct access to a broad range of lenders. They have three reportable segments which are Home, Consumer, and Insurance. The company generates match fees by matching consumers with lenders, and closing fees from lenders on loans when a transaction is closed. The company operates business solely in the United States.